| Diabetes management during breastfeeding in women with type 1 diabetes L Ringholm, EB Stougaard, SK Nørgaard, P Damm, ER Mathiesen Current diabetes reports 20, 1-8, 2020 | 16 | 2020 |
| Effects of butyrate supplementation on inflammation and kidney parameters in type 1 diabetes: a randomized, double-blind, placebo-controlled trial NH Tougaard, M Frimodt-Møller, H Salmenkari, EB Stougaard, ... Journal of clinical medicine 11 (13), 3573, 2022 | 12 | 2022 |
| Sodium–glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines EB Stougaard, P Rossing, D Cherney, D Vistisen, F Persson Journal of Diabetes and its Complications 36 (8), 108257, 2022 | 10 | 2022 |
| Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis EB Stougaard, PL Kristensen, U Kielgast, HU Andersen, Y Hamid, ... Diabetes and Vascular Disease Research 19 (5), 14791641221130043, 2022 | 6 | 2022 |
| Sotagliflozin, a dual sodium‐glucose co‐transporter‐1 and sodium‐glucose co‐transporter‐2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the … EB Stougaard, P Rossing, D Vistisen, P Banks, M Girard, MJ Davies, ... Diabetes, Obesity and Metabolism 25 (7), 1874-1882, 2023 | 4 | 2023 |
| Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes EB Stougaard, SA Winther, H Amadid, M Frimodt-Møller, F Persson, ... Plos one 16 (7), e0254859, 2021 | 4 | 2021 |
| Lower blood oxygen saturation is associated with microvascular complications in individuals with type 1 diabetes JC Laursen, HI Mizrak, H Kufaishi, SK Hecquet, EB Stougaard, ... The Journal of Clinical Endocrinology & Metabolism 108 (1), 99-106, 2023 | 3 | 2023 |
| Time Trends in the Incidence of Diabetic Ketoacidosis Leading to Hospital Admission Among Adults With Type 1 Diabetes: A Nationwide Danish Register Study EB Stougaard, H Amadid, E Søndergaard, B Carstensen, ME Jørgensen, ... Diabetes Care 46 (11), 1897-1902, 2023 | 2 | 2023 |
| Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and kidney disease as assessed by Steno T1 Risk Engine in adults with type 1 diabetes. EB Stougaard, P Rossing, D Vistisen, P Banks, M Girard, MJ Davies, ... Diabetes, Obesity & Metabolism, 2023 | 2 | 2023 |
| SGLT2-hæmmere til type 1-diabetes EB Stougaard, H Amadid, E Søndergaard, ME Jørgensen, F Persson, ... Ugeskr Læger 182, V05200351, 2020 | 1 | 2020 |
| Time trends in the incidence of diabetic ketoacidosis among adults with type 1 diabetes: a nationwide Danish register study EB Stougaard, H Amadid, E Sondergaard, B Carstensen, ME Jorgensen, ... Diabetologia 66 (SUPPL 1, 1), S57-S58, 2023 | | 2023 |
| Effects of Probiotics and Fibers on Markers of Nephropathy and Endothelial Dysfunction in Persons with Type 1 Diabetes and Albuminuria EB Stougaard, NH Tougaard, VR Curovic, S Sivalingam, CS Hansen, ... | | 2023 |
| New potential treatments for kidney disease in type 1 diabetes EB Stougaard | | 2023 |
| Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes: SA-PO263 EB Stougaard, P Rossing, D Vistisen, P Banks, M Girard, MJ Davies, ... Journal of the American Society of Nephrology 33 (11S), 674-675, 2022 | | 2022 |
| Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, reduces the risk of cardiovascular and renal disease as assessed by Steno Risk Engines in adults with type 1 diabetes EB Stougaard, P Rossing, D Vistisen, P Banks, M Girard, MJ Davies, ... Diabetologia 65 (SUPPL 1, 1, SI), S47, 2022 | | 2022 |
| 406-P: Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes—A Randomized, Double-Blind, Placebo-Controlled Trial NH TOUGAARD, M FRIMODT-MOELLER, H SALMENKARI, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| 396-P: Real-Life Evaluation of Sodium–Glucose Cotransporter 2 Inhibition in Type 1 Diabetes EB Stougaard, PL Kristensen, U Kielgast, SR ANDERSEN, U HENRIK, ... Diabetes 71 (Supplement_1), 2022 | | 2022 |
| Sodium-Glucose Cotransporter 2 Inhibitors as Adjunct Therapy for Type 1 Diabetes and the Benefit on Cardiovascular and Renal Disease Evaluated by Steno Risk Engines: SA-OR23 EB Stougaard, D Vistisen, F Persson, P Rossing Journal of the American Society of Nephrology 32 (10S), 45-46, 2021 | | 2021 |
| 380-P: Endothelial Glycocalyx Dimensions and Cardiovascular Risk Factors in Type 1 Diabetes EB Stougaard, S Winther, H Amadid, M Frimodt-Moeller, F Persson, ... Diabetes 70 (Supplement_1), 2021 | | 2021 |
| SGLT 2 inhibitors in Type 1 diabetes EB Stougaard, H Amadid, E Søndergaard, ME Jørgensen, F Persson, ... Ugeskrift for Laeger 182 (35), V05200351-V05200351, 2020 | | 2020 |
